Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumoursLoren Lasko, Kenneth D. Bromberg, Clarissa G. Jakob et al.|Nature|2017Cited by 853
Predicting the efficacy of radiotherapy in individual glioblastoma patients<i>in vivo:</i>a mathematical modeling approachRussell C. Rockne, Kristin R. Swanson, Jason K. Rockhill et al.|Physics in Medicine and Biology|2010Cited by 294
Prognostic Significance of Growth Kinetics in Newly Diagnosed Glioblastomas Revealed by Combining Serial Imaging with a Novel Biomathematical ModelChristina H. Wang, Kristin R. Swanson, Jason K. Rockhill et al.|Cancer Research|2009Cited by 245
Targeting histone acetylation dynamics and oncogenic transcription by catalytic P300/CBP inhibitionSimon J. Hogg, Ricky W. Johnstone, Izabela Todorovski et al.|Molecular Cell|2021Cited by 167